ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis, and evaluation of the in vitro activity of novel dual inhibitors of XOR and URAT1 containing a benzoic acid group

Zhu, Xin Ying; Chen, Hong Ming; Zhang, Lei; Qin, Yu Xiang; Li, Jing*
Chemical Biology and Drug Design2023-12DOI: 10.1111/cbdd.14348
10阅读
引用收藏
分享

摘要

Xanthine oxidoreductase (XOR) and uric acid transporter 1 (URAT1) are involved in the production and reabsorption of uric acid, respectively. However, the currently available individual XOR-or URAT1-targeted drugs have limited efficacy. Thus, strategies for combining XOR inhibitors with uricosuric drugs have been developed. Previous virtual screening identified Compounds 1-5 as hits for the potential dual inhibition of XOR/URAT1. Nevertheless, in vitro experiments yielded unsatisfactory results. The first round of optimization work on those hits was performed, and two series of compounds were designed and synthesized. Compounds of the A series exerted moderate inhibitory effects on URAT1, but extremely weak inhibitory effects on XOR. Compounds of the B series exerted strong inhibitory effects on both XOR and URAT1. B-5 exhibited the greatest inhibitory activity, with similar inhibitory effects on XOR and URAT1. The half maximal inhibitory concentration (IC50) of XOR was 0.012 +/- 0.001 mu M, equivalent to that of febuxostat (IC50 = 0.010 +/- 0.001 mu M). The IC50 of URAT1 was 30.24 +/- 3.46 mu M, equivalent to that of benzbromarone (IC50 = 24.89 +/- 7.53 mu M). Through this optimization, the in vitro activity of most compounds of the A and B series against XOR and URAT1 was significantly improved versus that of the hits. Compound B-5 should be further investigated.

学科与关键词

关键词
benzoic aciddual inhibitionoptimizationuric acid transporter 1xanthine oxidoreductase
相关
加载中…
  • Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methods
    Zhu, XinYing; Yang, Chao; Zhang, Lei; Li, Jing*Journal of Molecular Structure, 2022, 1256: 132567.被引 3
  • Synthesis and bioevaluation of 1-phenylimidazole-4-carboxylic acid derivatives as novel xanthine oxidoreductase inhibitors
    Zhou, Haiyan; Li, Xiaolei; Li, Yuanyuan; Zhu, Xinying; Zhang, Lei; Li, Jing*European Journal of Medicinal Chemistry, 2020, 186: 111883.被引 7
  • Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors
    Peng, Wen; Liu, Fuyao; Zhang, Lei; Zhang, Liying*; Li, Jing*European Journal of Medicinal Chemistry, 2023, 246: 114947.
查看全部 →

发表信息

论文状态
公开发表
期刊
Chemical Biology and Drug Design
发表日期
2023-12
卷期
第 102 卷, 第 6 期
页码
1553-1567
DOI
10.1111/cbdd.14348
语言
ENGLISH
成果收录
SCIE
资助标注
Guangzhou Municipal Science and Technology Project; Key-Area Research and Development Program of Guangdong Province

作者

  • Z

    Zhu, Xin Ying (第一作者)

  • C

    Chen, Hong Ming

查看全部 5 位作者收起作者
  • Z

    Zhang, Lei

  • Q

    Qin, Yu Xiang

  • L

    Li, Jing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417